Effect of Impaired Renal Function and Haemodialysis on the Pharmacokinetics of Aprepitant-Reference-Cited by-同舟云学术

Effect of Impaired Renal Function and Haemodialysis on the Pharmacokinetics of Aprepitant

Published:2005 Issue:6 Volume:44 Page:637-647
ISSN:0312-5963
Container-title:Clinical Pharmacokinetics
language:en
Short-container-title:Clinical Pharmacokinetics

Author:

Bergman Arthur J,Marbury Thomas,Fosbinder Trisha,Swan Suzanne,Hickey Lisa,Bradstreet Thomas E,Busillo John,Petty Kevin J,Viswanathan Aiyer Kala-Jyoti,Constanzer Marvin,Huskey Su-Er W,Majumdar Anup

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Reference15 articles.

1. The novel NK1 receptor antagonist MK–0869 (L–754,030) and its water soluble phosphoryl prodrug, L–758,298, inhibit acute and delayed cisplatin-induced emesis in ferrets

2. Reduction of Cisplatin-Induced Emesis by a Selective Neurokinin-1–Receptor Antagonist

3. Prevention of Cisplatin-Induced Emesis by the Oral Neurokinin-1 Antagonist, MK-869, in Combination With Granisetron and Dexamethasone or With Dexamethasone Alone

4. Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy-induced nausea and vomiting

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A pharmacological overview of aprepitant for the prevention of postoperative nausea and vomiting;Expert Review of Clinical Pharmacology;2023-05-08

2. Effects of 5‐HT ₃ receptor antagonists on cisplatin‐induced kidney injury;Clinical and Translational Science;2021-06-02

3. Effect of Disease State on the Pharmacokinetics of Bedaquiline in Renal-Impaired and Diabetic Rats;ACS Omega;2021-03-03

4. Combining biorelevant in vitro and in silico tools to simulate and better understand the in vivo performance of a nano-sized formulation of aprepitant in the fasted and fed states;European Journal of Pharmaceutical Sciences;2019-10

5. Successful management of refractory diabetic gastroparesis with long-term Aprepitant treatment;Diabetic Medicine;2017-09-18